ChemCon develops, manufactures, analyses and issues GMP releases for chemical products, specializing in small quantities from a few grams to several hundred kilograms with extensive documentation quality. The company has nearly 30 years of experience in organic, inorganic and polymer process development and produces APIs, excipients, provocation substances, in vivo/in vitro diagnostics, GMP starting materials, reference substances and dietary supplements. Extensive in‑house analytics and quality control services according to cGMP and ICH guidelines are integral to the offering and are also marketed as standalone services. In addition to CDMO contract synthesis, ChemCon runs a product business with self‑developed API products that constituted a significant share of revenue in the reporting year and is expected to increase substantially.
die Entwicklung, die Herstellung, der Vertrieb von und der Handel mit Grundstoffen und Substanzen für die pharmazeutische, chemische und biotechnologische und Nahrungsmittelindustrie sowie verwandten Industrien. Weiterhin wird Beratung für oben genannte Industrien auf insbesondere chemischen, biologischen, physikalischen, verfahrenstechnischen, medizinischen und biotechnologischen sowie damit verwandten Gebieten angeboten.
Converted using the official Destatis and Eurostat correspondence tables; ISIC Rev. 4 is the United Nations' international industry classification.
This summary was generated with the help of AI. See our Data Quality Notice. Report error?
Source: German Commercial Register (Handelsregister) Freiburg Local Court, HRB 5973 (as of 29 October 2026)
| Name | Type | City |
|---|---|---|
| Raphael Vogler | Geschäftsführer(in) | Freiburg im Breisgau |
Source: German Commercial Register (Handelsregister) Freiburg Local Court, HRB 5973 (as of 29 October 2026)
| Date | Event Type | Event |
|---|---|---|
| 29.04.2013 | Business Address Registered | Engesserstraße 4 b, 79108 Freiburg im Breisgau |
| 09.03.2006 | Company Name Registered | ChemCon GmbH |
| 09.03.2006 | Registered Seat | Freiburg im Breisgau |
| Date | Type | Change | Total Capital |
|---|---|---|---|
| 23.03.2006 | Share Capital Set | — | 30.000 € |
| 09.03.2006 | Share Capital Set | — | 30.000 DM |
Source: German Commercial Register (Handelsregister) Freiburg Local Court, HRB 5973 (as of 29 October 2026)
| Year | Revenue | Profit | Balance | Employees |
|---|---|---|---|---|
| 2025 | Rohergebnis€20M2 | €3,350,747 | €23,827,539 | — |
| 2024 | Rohergebnis€25.5M2 | €7,052,054 | €23,100,622 | — |
| 2023 | Rohergebnis€14.7M2 | €1,632,694 | €17,534,153 | — |
| 2022 | Rohergebnis€15.3M2 | €2,543,200 | €14,038,066 | — |
| 2021 | Rohergebnis€14M2 | €2,516,391 | €12,284,945 | — |
| 2020 | Rohergebnis€11.6M2 | €1,034,855 | €10,045,051 | — |
| 2019 | Rohergebnis€11.3M2 | €1,792,989 | €10,055,021 | — |
| 2018 | Rohergebnis€8.1M2 | €198,793 | €7,524,723 | — |
| 2017 | Rohergebnis€9.2M2 | €736,350 | €9,092,362 | — |
| 2016 | Rohergebnis€9M2 | €988,387 | €6,456,342 | — |
1 Small companies are not required to publish a profit-and-loss statement (§ 326 (1) HGB). The figure shown is the statutory ceiling under § 267 HGB where the balance-sheet total makes it binding — a company may exceed at most one of the three size criteria.
2 Rohergebnis nach § 276 HGB: Umsatzerlöse abzüglich Materialaufwand bzw. Herstellungskosten. Kleine und mittelgroße Kapitalgesellschaften dürfen diese Posten zusammenfassen; die Umsatzerlöse selbst sind dann nicht veröffentlicht und liegen über dem Rohergebnis.
Sign in to download data
Source: German Commercial Register (Handelsregister) Freiburg Local Court, HRB 5973 (as of 29 October 2026)
| Cost type | Amount | Share |
|---|---|---|
| Personnel Costs | €8,274,793 | 80.0% |
| Depreciation | €2,053,361 | 19.9% |
| Interest & Similar | €15,394 | 0.1% |
